draft cvtsymposiumbrochure outside...friday, june 3, 2016 7:45 a.m. – 5:30 p.m. new york athletic...

4
Friday, June 3, 2016 7:45 a.m. – 5:30 p.m. New York Athletic Club 180 Central Park South New York City Your compliance with the New York Athletic Club’s dress code is required. Dress Code: Inappropriate attire includes jeans and other denim wear, shorts, t-shirts and athletic wear, halter tops, sandals and leggings. Required: Business casual attire, with jacket, for men and comparable attire for women PROGRAM DESCRIPTION AND TARGET AUDIENCE e Ninth Annual Cardiovascular Team Symposium 2016, presented by e New York Cardiological Society, is a unique academic event designed to enhance current knowledge about the etiology, prevention, intervention and management of cardiovascular disease. Presentations will provide cardiovascular team members with evidence-based approaches to the treatment and care of the cardiac patient and information regarding current and new cutting edge technologies. e target audience includes nurse practitioners, physician assistants, technologists, physicians and all members of the cardiovascular team. NEEDS STATEMENT Demand for cardiac care continues to increase due to the aging population, the obesity epidemic and the persistent incidence of cardiovascular disease in the population. At present, cardiovascular disease is still by far the most common diagnosis among all hospital discharges in the United States. Chronic disease will become an important component of cardiology practice and care teams, consisting of nurses, nurse practitioners, physician assistants, pharmacists and physicians, and will provide the most efficient means of providing ongoing care and long-term follow-up and management of cardiovascular patients. e Symposium will address relevant topics, including hypertrophic cardiomyopathy, major hurdles that the American College of Cardiology is facing, cardiovascular care in cancer patients, anti-platelet therapy strategies for instent restenosis, risks associated with stroke in patients with a left atrial appendage occlusion device, the pathophysiology of PCSK9 inhibitors and appropriate patients for therapy, SPRINT trail data, CardioMEMS monitoring in heart failure patients, treatment/guidelines for pulmonary embolism, and an interesting case study. ere will be ample time for Q&A and discussion. GOAL STATEMENT e overall goal of this activity is to improve patient care by increasing learner knowledge and competence. At the completion of the Symposium, learners will be able to: Describe major hurdles that the American College of Cardiology is facing and those of the cardiology profession in general Explain risks associated with stroke in patients on anticoagulation or with a left atrial appendage occlusion device Describe the clinical symptoms of patients presenting with pulmonary embolism and discuss the current guidelines regarding diagnosis, treatment of pulmonary embolism and ways to reduce sequelae Describe how the pulmonary embolism response team is an effective management strategy for patients with pulmonary embolism Identify new therapeutic strategies that can improve clinical outcomes for instent restenosis Classify appropriate patients for PCSK9 inhibitor therapy and explain the pathophysiology of PCSK9 inhibitors Explain the role of outpatient pulmonary artery pressure monitoring in managing patients with reduced ejection fraction and preserved ejection fraction heart failure Identify the institutional support structure needed to manage a CardioMEMS program Discuss the different forms of therapy for HCOM and the rationale of betablockers, non-dihyrdophryidine calcium channel blockers, and disopyramide, as well as the limitations of medical therapy Identify indicators for surgical septal myectomy and alcohol septal ablation Identify agents most likely implicated in the development of myocardial dysfunction and heart failure, including their mechanisms of action Discuss early surveillance by both biomarker and imaging approaches in the cancer population Recite the benefits of blood pressure reduction in patients at an increased risk of a cardiovascular event Discuss forms of congestive heart failure including ischemic/non-ischemic cardiomyopathy, structural heart disease, and pulmonary hypertension State the elements required for informed refusal of potentially life-saving treatments PROGRAM OBJECTIVES NINTH ANNUAL CARDIO- VASCULAR TEAM SYMPOSIUM 2016 Presented by of the in association with Jointly Provided by

Upload: others

Post on 05-Jul-2020

3 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: DRAFT CVTSymposiumBrochure Outside...Friday, June 3, 2016 7:45 a.m. – 5:30 p.m. New York Athletic Club 180 Central Park South New York City Your compliance with the New York Athletic

Friday, June 3, 20167:45 a.m. – 5:30 p.m.

New York Athletic Club180 Central Park SouthNew York City

Your compliance with the New York Athletic Club’sdress code is required.

Dress Code: Inappropriate attire includes jeans and

other denim wear, shorts, t-shirts and athletic wear, halter tops, sandals and leggings.

Required: Business casual attire, with jacket, for men and comparable attire for women�

e New

Yor

k C

ardi

olog

ical

Soc

iety

, Inc

.55

5 8t

h A

venu

e, Su

ite 1

902

New

Yor

k, N

Y 1

0018

PROGRAM DESCRIPTION AND TARGET AUDIENCE�e Ninth Annual Cardiovascular Team Symposium 2016, presented by �e New York Cardiological Society, is a unique academic event designed to enhance current knowledge about the etiology, prevention, intervention and management of cardiovascular disease. Presentations will provide cardiovascular team members with evidence-based approaches to the treatment and care of the cardiac patient and information regarding current and new cutting edge technologies. �e target audience includes nurse practitioners, physician assistants, technologists, physicians and all members of the cardiovascular team.

NEEDS STATEMENTDemand for cardiac care continues to increase due to the aging population, the obesity epidemic and the persistent incidence of cardiovascular disease in the population. At present, cardiovascular disease is still by far the most common diagnosis among all hospital discharges in the United States. Chronic disease will become an important component of cardiology practice and care teams, consisting of nurses, nurse practitioners, physician assistants, pharmacists and physicians, and will provide the most e�cient means of providing ongoing care and long-term follow-up and management of cardiovascular patients. �e Symposium will address relevant topics, including hypertrophic cardiomyopathy, major hurdles that the American College of Cardiology is facing, cardiovascular care in cancer patients, anti-platelet therapy strategies for instent restenosis, risks associated with stroke in patients with a left atrial appendage occlusion device, the pathophysiology of PCSK9 inhibitors and appropriate patients for therapy, SPRINT trail data, CardioMEMS monitoring in heart failure patients, treatment/guidelines for pulmonary embolism, and an interesting case study. �ere will be ample time for Q&A and discussion.

GOAL STATEMENT�e overall goal of this activity is to improve patient care by increasing learner knowledge and competence.

At the completion of the Symposium, learners will be able to:• Describe major hurdles that the American College of Cardiology is facing and those of the cardiology

profession in general

• Explain risks associated with stroke in patients on anticoagulation or with a left atrial appendage occlusiondevice

• Describe the clinical symptoms of patients presenting with pulmonary embolism and discuss the currentguidelines regarding diagnosis, treatment of pulmonary embolism and ways to reduce sequelae

• Describe how the pulmonary embolism response team is an e�ective management strategy for patients withpulmonary embolism

• Identify new therapeutic strategies that can improve clinical outcomes for instent restenosis

• Classify appropriate patients for PCSK9 inhibitor therapy and explain the pathophysiology of PCSK9 inhibitors

• Explain the role of outpatient pulmonary artery pressure monitoring in managing patients with reducedejection fraction and preserved ejection fraction heart failure

• Identify the institutional support structure needed to manage a CardioMEMS program

• Discuss the di�erent forms of therapy for HCOM and the rationale of betablockers, non-dihyrdophryidinecalcium channel blockers, and disopyramide, as well as the limitations of medical therapy

• Identify indicators for surgical septal myectomy and alcohol septal ablation

• Identify agents most likely implicated in the development of myocardial dysfunction and heart failure, including their mechanisms of action

• Discuss early surveillance by both biomarker and imaging approaches in the cancer population

• Recite the bene�ts of blood pressure reduction in patients at an increased risk of a cardiovascular event

• Discuss forms of congestive heart failure including ischemic/non-ischemic cardiomyopathy, structural heart disease, and pulmonary hypertension

• State the elements required for informed refusal of potentially life-saving treatments

PROGRAM OBJECTIVES

REGISTRATION FORM

NINTH ANNUALCARDIOVASCULARTEAM SYMPOSIUM 2016 Online registration available at: www.NYCardiology.org

YOUR EMAIL, ADDRESS, AND DEGREE(S) MUST BE INCLUDED

NAME

EMAIL

RN NP PA MD DO PHD OTHER

ADDRESS LINE 1

ADDRESS LINE 2

ADDRESS LINE 3

ORGANIZATION NAME

PHONE #

I’M A MEMBER OF THE NEW YORK STATE CHAPTER, AMERICAN COLLEGE OF CARDIOLOGY (NY-ACC)

I’M NOT A MEMBER BUT AM INTERESTED IN RECEIVING INFORMATION ABOUT MEMBERSHIP

NY-ACC Member: $100 Non-Member (Before May 2): $150 Non-Member (On or after May 2): $165

Walk-in / Day-of Registration: $180

Total # of registrants $ Total amount enclosed

Please make checks payable to: �e New York Cardiological Society, Inc.

Registration form and remittance should be mailed to:�e New York Cardiological Society, Inc.555 8th Ave., Suite 1902New York, New York 10018

ACCREDITATION �is activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Rochester School of Medicine and Dentistry and �e New York Cardiological Society, Inc. �e University of Rochester School of Medicine and Dentistry is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CERTIFICATION�e University of Rochester School of Medicine and Dentistry designates this live activity for a maximum of 7.0 AMA PRA Category 1 Credit(s).™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NEW YORK CARDIOLOGICALSOCIETY DISCLOSURESTATEMENT�e New York Cardiological Society, Inc. relies uponinvited faculty participants in its CME programs to provide educational information that is objective and free of bias. In this spirit, and in accordance with the guidelines of the program sponsor, faculty participants are expected to indicate any commercial relationship that might be perceived as a real or apparent con�ictof interest. Any discussion of investigational or unlabeled uses of a product will be identi�ed.

NINTH ANNUAL

CARDIO-VASCULAR TEAM SYMPOSIUM2016

Questions? Call (212) 686-0228 or email [email protected]

* Kindly tell us where you heard about this year’s event

* Please print

Presented by

of the

in association with

Jointly Provided by

Page 2: DRAFT CVTSymposiumBrochure Outside...Friday, June 3, 2016 7:45 a.m. – 5:30 p.m. New York Athletic Club 180 Central Park South New York City Your compliance with the New York Athletic

Je�rey Berger, MD, FACCNew York University Langone Medical Center

Michelle Bloom, MD, FACCStony Brook University Medical Center

Marianne Chiafery, MSN, PNP, MSUniversity of Rochester Schools of Nursing and Medicine

Larry A. Chinitz, MDNew York University Langone Medical Center

James Horowitz, MD, FACCWeill Cornell Medical College

Erica Jones, MD, FACCWeill Cornell Medical College

Roxana Mehran, MD, FACCMount Sinai School of Medicine

Michael Querijero, PANew York University Langone Medical Center

Alexander Reyentovich, MDNew York University Langone Medical Center

Akhilesh K. Sista, MDNew York University Langone Medical Center

Maria Spinelli, ANP-BCNew York-Presbyterian Hospital/ Weill Cornell Medical College

Daniel G. Swistel, MDNew York University Langone Medical Center

Kim Allan Williams, Sr., MD, FACCRush University Medical Center

FACULTY

PLANNING COMMITTEE

Michael Querijero, PA Co-Chair New York University Langone Medical Center

Maria Spinelli, ANP-BC Co-Chair, Downstate CVT RepresentativeNew York–Presbyterian Hospital/Weill Cornell Medical College

Alice Arden, ANP-BCNew York–Presbyterian Hospital/Weill Cornell Medical College

Maureen Gaus, RNSt. Francis Hospital

Maureen Geary, ANP-BCNew York University Langone Medical Center

Patricia Geraghty, PA-CWinthrop-University Hospital

Lisa Kotyra, NPUpstate CVT Representative University of Rochester Medical Center

Kena Patel, PA-CNew York–Presbyterian Hospital/Weill Cornell Medical College

Crystalisa Peltz, DNPNew York–Presbyterian Hospital/Weill Cornell Medical College

Tracey Shannon, ANP-BCNew York–Presbyterian Hospital/Weill Cornell Medical College

O�cersWilliam Lawson, MDPresident

Leway Chen, MD, MPHImmediate Past President

Timothy C. Dutta, MDSecretary-Treasurer

Executive BoardJohn Bisognano, MD, PhDJe�rey S. Borer, MDLeway Chen, MD, MPHPeter F. Cohn, MDPaul Klig�eld, MD Smadar Kort, MDJoseph Lauterstein, MDJames T. Mazzara, MDHarry C. Odabashian, Jr., MDHarold Smulyan, MD Andrew VanTosh, MDDaniel J. Williford, MD, PhDMohammad Zahir, MD

THE NEW YORK CARDIOLOGICAL SOCIETY, INC.

O�cersTim Malins, MDPresident

Smadar Kort, MDImmediate Past President

Timothy C. Dutta, MDSecretary-Treasurer

Executive DirectorMary E. Leslie, MA, MSA

CouncilorsRichard Charney, MD, New RochelleJay J. Dubowsky, MD, ManhassetSei Iwai, MD, ValhallaStanley Fernandez, MD, BuffaloNorma Keller, MD, ManhattanLloyd Lense, MD, Stony BrookAmgad N. Makaryus, MD, East MeadowCharles J. Lowenstein, MD, RochesterAshok Patel, MD, UticaRobert S. Phang, MD, AlbanyBrian Riegel, MD, BuffaloMichael Sassower, MD, Utica Benjamin Schaefer, MD, RhinebeckMandeep Sidhu, MD, AlbanyRajesh V. Swaminathan, MD, ManhattanJ. Chad Teeters, MD, Rochester�eodore I. Tyberg, MD, Manhattan

CVT RepresentativesMaria Spinelli, NP, DownstateLisa Kotyra, NP, Upstate

FIT RepresentativesEdon Rabinowitz, MD, DownstateJunsoo Alex Lee, MD, Upstate

Delegate to MSSNYJoseph Tartaglia, MD

NEW YORK STATE CHAPTER,AMERICAN COLLEGE OF CARDIOLOGY

O�cersRichard GlazerPresident

Michael Wolk, MDExecutive Vice President

David M. CordermanSecretary

Alfred S. Glazier Treasurer

Board of GovernorsMichael Beals, DDSEdward BindelDavid M. CordermanHon. Bertram GelfandDavid Glazer, Esq.Richard GlazerAlfred S. GlazierJerome GoldsteinEric Martins, Esq.Jo�rey PearlmanMichael Rogow, DDSLisa Troy, MDMichael Wolk, MDRobert Wolk

NEW YORK CARDIAC CENTER

7:45 a.m. REGISTRATION, EXHIBITS AND CONTINENTAL BREAKFAST

8:15 a.m. WELCOMING REMARKS

Timothy Malins, MD, FACC President, �e New York State Chapter of the American College of Cardiology

William Lawson, MD, FACC President, �e New York Cardiological Society, Inc.

8:20 a.m. KEYNOTE PRESENTATION - “STATE OF THE COLLEGE”

Kim Allan Williams, Sr., MD, FACC Immediate Past President, American College of Cardiology Rush University Medical Center

8:50 a.m. Q & A

9:05 a.m. ALTERNATIVES TO ANTICOAGULATION: LEFT ATRIAL APPENDAGE OCCLUSION

Larry A. Chinitz, MDNew York University Langone Medical Center

9:40 a.m. TREATMENT OF PULMONARY EMBOLISM IN 2016

James Horowitz, MD, FACC Weill Cornell Medical College

Akhilesh K. Sista, MDNew York University Langone Medical Center

10:15 a.m. Q & A

10:25 a.m. BREAK & EXHIBITS

10:40 a.m. INSTENT RESTENOSIS: NOVEL STRATEGIES & UPDATES ON ANTI-PLATELET THERAPY STRATEGIES

Roxana Mehran, MD, FACCMount Sinai School of Medicine

11:15 a.m. PCSK9 INHIBITORS: A NEW CLASS OF LIPID-LOWERING THERAPIES…WILL THEY LIVE UP TO THE HYPE?

Erica Jones, MD, FACC Weill Cornell Medical College

11:50 a.m. Q & A

12:00 p.m. LUNCH, REVIEW OF MORNING TALKS AND EXHIBIT

1:00 p.m. CARDIOMEMS MONITORING IN THE HEART FAILUREPATIENT

Alexander Reyentovich, MDNew York University Langone Medical Center

1:35 p.m. HYPERTROPHIC CARDIOMYOPATHY: PATHOPHYSIOLOGY, DIAGNOSIS & TREATMENT OPTIONS

Daniel Swistel, MDNew York University Langone Medical Center

2:10 p.m. Q & A

2:25 p.m. CARDIO-ONCOLOGY APPROACHES TO CARDIOVASCULAR CARE IN THE CANCER PATIENT

Michelle Bloom, MD, FACCStony Brook University Medical Center

2:55 p.m. Q & A

3:00 p.m. HYPERTENSION: MODIFIED GUIDELINES FOR HEALTHCARE PROVIDERS

Je�rey Berger, MD, FACC New York University Langone Medical Center

3:35 p.m. AN INTERESTING CASE STUDY

Marianne Chiafery, MSN, PNP, MSUniversity of Rochester Schools of Nursing and Medicine

4:05 p.m. Q & A

4:15 p.m. REVIEW & CLOSING REMARKS

Michael Querijero, PA New York University Langone Medical Center

Maria Spinelli, ANP-BCNew York–Presbyterian Hospital/Weill Cornell Medical College

4:30 p.m. WINE AND CHEESE NETWORKING EVENT

Page 3: DRAFT CVTSymposiumBrochure Outside...Friday, June 3, 2016 7:45 a.m. – 5:30 p.m. New York Athletic Club 180 Central Park South New York City Your compliance with the New York Athletic

Je�rey Berger, MD, FACCNew York University Langone Medical Center

Michelle Bloom, MD, FACCStony Brook University Medical Center

Marianne Chiafery, MSN, PNP, MSUniversity of Rochester Schools of Nursing and Medicine

Larry A. Chinitz, MDNew York University Langone Medical Center

James Horowitz, MD, FACCWeill Cornell Medical College

Erica Jones, MD, FACCWeill Cornell Medical College

Roxana Mehran, MD, FACCMount Sinai School of Medicine

Michael Querijero, PANew York University Langone Medical Center

Alexander Reyentovich, MDNew York University Langone Medical Center

Akhilesh K. Sista, MDNew York University Langone Medical Center

Maria Spinelli, ANP-BCNew York-Presbyterian Hospital/ Weill Cornell Medical College

Daniel G. Swistel, MDNew York University Langone Medical Center

Kim Allan Williams, Sr., MD, FACCRush University Medical Center

FACULTY

PLANNING COMMITTEE

Michael Querijero, PA Co-Chair New York University Langone Medical Center

Maria Spinelli, ANP-BC Co-Chair, Downstate CVT RepresentativeNew York–Presbyterian Hospital/Weill Cornell Medical College

Alice Arden, ANP-BCNew York–Presbyterian Hospital/Weill Cornell Medical College

Maureen Gaus, RNSt. Francis Hospital

Maureen Geary, ANP-BCNew York University Langone Medical Center

Patricia Geraghty, PA-CWinthrop-University Hospital

Lisa Kotyra, NPUpstate CVT Representative University of Rochester Medical Center

Kena Patel, PA-CNew York–Presbyterian Hospital/Weill Cornell Medical College

Crystalisa Peltz, DNPNew York–Presbyterian Hospital/Weill Cornell Medical College

Tracey Shannon, ANP-BCNew York–Presbyterian Hospital/Weill Cornell Medical College

O�cersWilliam Lawson, MDPresident

Leway Chen, MD, MPHImmediate Past President

Timothy C. Dutta, MDSecretary-Treasurer

Executive BoardJohn Bisognano, MD, PhDJe�rey S. Borer, MDLeway Chen, MD, MPHPeter F. Cohn, MDPaul Klig�eld, MD Smadar Kort, MDJoseph Lauterstein, MDJames T. Mazzara, MDHarry C. Odabashian, Jr., MDHarold Smulyan, MD Andrew VanTosh, MDDaniel J. Williford, MD, PhDMohammad Zahir, MD

THE NEW YORK CARDIOLOGICAL SOCIETY, INC.

O�cersTim Malins, MDPresident

Smadar Kort, MDImmediate Past President

Timothy C. Dutta, MDSecretary-Treasurer

Executive DirectorMary E. Leslie, MA, MSA

CouncilorsRichard Charney, MD, New RochelleJay J. Dubowsky, MD, ManhassetSei Iwai, MD, ValhallaStanley Fernandez, MD, BuffaloNorma Keller, MD, ManhattanLloyd Lense, MD, Stony BrookAmgad N. Makaryus, MD, East MeadowCharles J. Lowenstein, MD, RochesterAshok Patel, MD, UticaRobert S. Phang, MD, AlbanyBrian Riegel, MD, BuffaloMichael Sassower, MD, Utica Benjamin Schaefer, MD, RhinebeckMandeep Sidhu, MD, AlbanyRajesh V. Swaminathan, MD, ManhattanJ. Chad Teeters, MD, Rochester�eodore I. Tyberg, MD, Manhattan

CVT RepresentativesMaria Spinelli, NP, DownstateLisa Kotyra, NP, Upstate

FIT RepresentativesEdon Rabinowitz, MD, DownstateJunsoo Alex Lee, MD, Upstate

Delegate to MSSNYJoseph Tartaglia, MD

NEW YORK STATE CHAPTER,AMERICAN COLLEGE OF CARDIOLOGY

O�cersRichard GlazerPresident

Michael Wolk, MDExecutive Vice President

David M. CordermanSecretary

Alfred S. Glazier Treasurer

Board of GovernorsMichael Beals, DDSEdward BindelDavid M. CordermanHon. Bertram GelfandDavid Glazer, Esq.Richard GlazerAlfred S. GlazierJerome GoldsteinEric Martins, Esq.Jo�rey PearlmanMichael Rogow, DDSLisa Troy, MDMichael Wolk, MDRobert Wolk

NEW YORK CARDIAC CENTER

7:45 a.m. REGISTRATION, EXHIBITS AND CONTINENTAL BREAKFAST

8:15 a.m. WELCOMING REMARKS

Timothy Malins, MD, FACC President, �e New York State Chapter of the American College of Cardiology

William Lawson, MD, FACC President, �e New York Cardiological Society, Inc.

8:20 a.m. KEYNOTE PRESENTATION - “STATE OF THE COLLEGE”

Kim Allan Williams, Sr., MD, FACC Immediate Past President, American College of Cardiology Rush University Medical Center

8:50 a.m. Q & A

9:05 a.m. ALTERNATIVES TO ANTICOAGULATION: LEFT ATRIAL APPENDAGE OCCLUSION

Larry A. Chinitz, MD New York University Langone Medical Center

9:40 a.m. TREATMENT OF PULMONARY EMBOLISM IN 2016

James Horowitz, MD, FACC Weill Cornell Medical College

Akhilesh K. Sista, MD New York University Langone Medical Center

10:15 a.m. Q & A

10:25 a.m. BREAK & EXHIBITS

10:40 a.m. INSTENT RESTENOSIS: NOVEL STRATEGIES & UPDATES ON ANTI-PLATELET THERAPY STRATEGIES

Roxana Mehran, MD, FACC Mount Sinai School of Medicine

11:15 a.m. PCSK9 INHIBITORS: A NEW CLASS OF LIPID-LOWERING THERAPIES…WILL THEY LIVE UP TO THE HYPE?

Erica Jones, MD, FACC Weill Cornell Medical College

11:50 a.m. Q & A

12:00 p.m. LUNCH, REVIEW OF MORNING TALKS AND EXHIBIT

1:00 p.m. CARDIOMEMS MONITORING IN THE HEART FAILURE PATIENT

Alexander Reyentovich, MD New York University Langone Medical Center

1:35 p.m. HYPERTROPHIC CARDIOMYOPATHY: PATHOPHYSIOLOGY, DIAGNOSIS & TREATMENT OPTIONS

Daniel Swistel, MD New York University Langone Medical Center

2:10 p.m. Q & A

2:25 p.m. CARDIO-ONCOLOGY APPROACHES TO CARDIOVASCULAR CARE IN THE CANCER PATIENT

Michelle Bloom, MD, FACC Stony Brook University Medical Center

2:55 p.m. Q & A

3:00 p.m. HYPERTENSION: MODIFIED GUIDELINES FOR HEALTHCARE PROVIDERS

Je�rey Berger, MD, FACC New York University Langone Medical Center

3:35 p.m. AN INTERESTING CASE STUDY

Marianne Chiafery, MSN, PNP, MS University of Rochester Schools of Nursing and Medicine

4:05 p.m. Q & A

4:15 p.m. REVIEW & CLOSING REMARKS

Michael Querijero, PA New York University Langone Medical Center

Maria Spinelli, ANP-BC New York–Presbyterian Hospital/Weill Cornell Medical College

4:30 p.m. WINE AND CHEESE NETWORKING EVENT

Page 4: DRAFT CVTSymposiumBrochure Outside...Friday, June 3, 2016 7:45 a.m. – 5:30 p.m. New York Athletic Club 180 Central Park South New York City Your compliance with the New York Athletic

Friday, June 3, 20167:45 a.m. – 5:30 p.m.

New York Athletic Club180 Central Park SouthNew York City

Your compliance with the New York Athletic Club’sdress code is required.

Dress Code:Inappropriate attire includes jeans and

other denim wear, shorts, t-shirts and athletic wear, halter tops, sandals and leggings.

Required: Business casual attire, with jacket, for men and comparable attire for women�

e New

Yor

k C

ardi

olog

ical

Soc

iety

, Inc

.55

5 8t

h A

venu

e, Su

ite 1

902

New

Yor

k, N

Y 1

0018

PROGRAM DESCRIPTION AND TARGET AUDIENCE�e Ninth Annual Cardiovascular Team Symposium 2016, presented by �e New York Cardiological Society, is a unique academic event designed to enhance current knowledge about the etiology, prevention, intervention and management of cardiovascular disease. Presentations will provide cardiovascular team members with evidence-based approaches to the treatment and care of the cardiac patient and information regarding current and new cutting edge technologies. �e target audience includes nurse practitioners, physician assistants, technologists, physicians and all members of the cardiovascular team.

NEEDS STATEMENTDemand for cardiac care continues to increase due to the aging population, the obesity epidemic and the persistent incidence of cardiovascular disease in the population. At present, cardiovascular disease is still by far the mostcommon diagnosis among all hospital discharges in the United States. Chronic disease will become an important component of cardiology practice and care teams, consisting of nurses, nurse practitioners, physician assistants, pharmacists and physicians, and will provide the most e�cient means of providing ongoing care and long-term follow-up and management of cardiovascular patients. �e Symposium will address relevant topics, including hypertrophic cardiomyopathy, major hurdles that the American College of Cardiology is facing, cardiovascular care in cancer patients, anti-platelet therapy strategies for instent restenosis, risks associated with stroke in patients with a left atrial appendage occlusion device, the pathophysiology of PCSK9 inhibitors and appropriate patients for therapy, SPRINT trail data, CardioMEMS monitoring in heart failure patients, treatment/guidelines for pulmonary embolism, and an interesting case study. �ere will be ample time for Q&A and discussion.

GOAL STATEMENT�e overall goal of this activity is to improve patient care by increasing learner knowledge and competence.

At the completion of the Symposium, learners will be able to:• Describe major hurdles that the American College of Cardiology is facing and those of the cardiology

profession in general

• Explain risks associated with stroke in patients on anticoagulation or with a left atrial appendage occlusion device

• Describe the clinical symptoms of patients presenting with pulmonary embolism and discuss the current guidelines regarding diagnosis, treatment of pulmonary embolism and ways to reduce sequelae

• Describe how the pulmonary embolism response team is an e�ective management strategy for patients with pulmonary embolism

• Identify new therapeutic strategies that can improve clinical outcomes for instent restenosis

• Classify appropriate patients for PCSK9 inhibitor therapy and explain the pathophysiology of PCSK9 inhibitors

• Explain the role of outpatient pulmonary artery pressure monitoring in managing patients with reduced ejection fraction and preserved ejection fraction heart failure

• Identify the institutional support structure needed to manage a CardioMEMS program

• Discuss the di�erent forms of therapy for HCOM and the rationale of betablockers, non-dihyrdophryidine calcium channel blockers, and disopyramide, as well as the limitations of medical therapy

• Identify indicators for surgical septal myectomy and alcohol septal ablation

• Identify agents most likely implicated in the development of myocardial dysfunction and heart failure, including their mechanisms of action

• Discuss early surveillance by both biomarker and imaging approaches in the cancer population

• Recite the bene�ts of blood pressure reduction in patients at an increased risk of a cardiovascular event

• Discuss forms of congestive heart failure including ischemic/non-ischemic cardiomyopathy, structural heart disease, and pulmonary hypertension

• State the elements required for informed refusal of potentially life-saving treatments

PROGRAM OBJECTIVES

REGISTRATION FORM

NINTH ANNUALCARDIOVASCULARTEAM SYMPOSIUM 2016 Online registration available at: www.NYCardiology.org

YOUR EMAIL, ADDRESS, AND DEGREE(S) MUST BE INCLUDED

NAME

EMAIL

RN NP PA MD DO PHD OTHER

ADDRESS LINE 1

ADDRESS LINE 2

ADDRESS LINE 3

ORGANIZATION NAME

PHONE #

I’M A MEMBER OF THE NEW YORK STATE CHAPTER, AMERICAN COLLEGE OF CARDIOLOGY (NY-ACC)

I’M NOT A MEMBER BUT AM INTERESTED IN RECEIVING INFORMATION ABOUT MEMBERSHIP

NY-ACC Member: $100 Non-Member (Before May 2): $150 Non-Member (On or after May 2): $165 Walk-in / Day-of Registration: $180

Total # of registrants $ Total amount enclosed

Please make checks payable to: �e New York Cardiological Society, Inc.

Registration form and remittance should be mailed to:�e New York Cardiological Society, Inc.555 8th Ave., Suite 1902New York, New York 10018

ACCREDITATION �is activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Rochester School of Medicine and Dentistry and �e New York Cardiological Society, Inc. �e University of Rochester School of Medicine and Dentistry is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CERTIFICATION�e University of Rochester School of Medicine and Dentistry designates this live activity for a maximum of 7.0 AMA PRA Category 1 Credit(s).™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NEW YORK CARDIOLOGICAL SOCIETY DISCLOSURE STATEMENT�e New York Cardiological Society, Inc. relies upon invited faculty participants in its CME programs to provide educational information that is objective and free of bias. In this spirit, and in accordance with the guidelines of the program sponsor, faculty participants are expected to indicate any commercial relationship that might be perceived as a real or apparent con�ict of interest. Any discussion of investigational or unlabeled uses of a product will be identi�ed.

NINTH ANNUAL

CARDIO-VASCULAR TEAM SYMPOSIUM2016

Questions? Call (212) 686-0228 or email [email protected]

* Kindly tell us where you heard about this year’s event

* Please print

Presented by

of the

in association with

Jointly Provided by